Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958–2005

References

• Abend M, Pfeiffer RM, Ruf C, Hatch M, Bogdanova TI, Tronko MD, Hartmann J, Meineke V, Mabuchi K, Brenner AV. 2013. Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers. Br J Cancer. 109(8):2286–2294.
   PubMed Web of Science ®Google Scholar
• Agrawal N, Akbani R, Aksoy BA, Ally A, Arachchi H, Asa SL, Auman JT, Balasundaram M, Balu S, Baylin SB, et al. 2014. Integrated Genomic Characterization of Papillary Thyroid Carcinoma. Cell. 159(3):676–690.
   PubMed Web of Science ®Google Scholar
• Behjati S, Gundem G, Wedge DC, Roberts ND, Tarpey PS, Cooke SL, Loo PV, Alexandrov LB, Ramakrishna M, Davies H, ICGC Prostate Group, et al. 2016. Mutational signatures of ionizing radiation in second malignancies. Nat Commun. 7:12605.
   PubMed Web of Science ®Google Scholar
• Bianconi E, Piovesan A, Facchin F, Beraudi A, Casadei R, Frabetti F, Vitale L, Pelleri MC, Tassani S, Piva F, et al. 2013. An estimation of the number of cells in the human body. Ann Hum Biol. 40(6):463–471.
   PubMed Web of Science ®Google Scholar
• Bogdanova TI, Zurnadzhy LY, Nikiforov YE, Leeman-Neill RJ, Tronko MD, Chanock S, Mabuchi K, Likhtarov IA, Kovgan LM, Drozdovitch V, et al. 2015. Histopathological features of papillary thyroid carcinomas detected during four screening examinations of a Ukrainian-American cohort. Br J Cancer. 113(11):1556–1564.
   PubMed Web of Science ®Google Scholar
• Bolker B, RDC Team. 2017. BBMLE: tools for general maximum likelihood estimation. R package version 1.0.20. https://CRAN.R-project.org/package=bbmle.
   Google Scholar
• Brenner AV, Tronko MD, Hatch M, Bogdanova TI, Oliynik VA, Lubin JH, Zablotska LB, Tereschenko VP, McConnell RJ, Zamotaeva GA, et al. 2011. I-131 dose response for incident thyroid cancers in Ukraine related to the Chernobyl accident. Environ Health Perspect. 119(7):933–939.
   PubMed Web of Science ®Google Scholar
• Castelletti N, Kaiser JC, Simonetto C, Furukawa K, Küchenhoff H, Stathopoulos GT. 2019. Risk of lung adenocarcinoma from smoking and radiation arises in distinct molecular pathways. Carcinogenesis. 40(10):1240–1250.
   PubMed Web of Science ®Google Scholar
• Coclet J, Foureau F, Ketelbant P, Galand P, Dumont JE. 1989. Cell population kinetics in dog and human adult thyroid. Clin Endocrinol (Oxf)). 31(6):655–665.
   PubMed Web of Science ®Google Scholar
• Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. 2006. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res. 166(1 Pt 2):219–254.
   PubMed Web of Science ®Google Scholar
• Dom G, Tarabichi M, Unger K, Thomas G, Oczko-Wojciechowska M, Bogdanova T, Jarzab B, Dumont JE, Detours V, Maenhaut C. 2012. A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer. 107(6):994–1000.
   PubMed Web of Science ®Google Scholar
• Dumont JE, Lamy F, Roger P, Maenhaut C. 1992. Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev. 72(3):667–697.
   PubMed Web of Science ®Google Scholar
• Efanov AA, Brenner AV, Bogdanova TI, Kelly LM, Liu P, Little MP, Wald AI, Hatch M, Zurnadzy LY, Nikiforova MN, et al. 2018. Investigation of the relationship between radiation dose and gene mutations and fusions in post-Chernobyl thyroid cancer. J Natl Cancer Inst. 110(4):371–378.
   PubMedGoogle Scholar
• Fernandez-Antoran D, Piedrafita G, Murai K, Ong SH, Herms A, Frezza C, Jones PH. 2019. Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell. 25(3):329–341.e6.
   PubMed Web of Science ®Google Scholar
• Fierabracci A. 2012. Identifying thyroid stem/progenitor cells: advances and limitations. J Endocrinol. 213(1):1–13.
   PubMed Web of Science ®Google Scholar
• Fukushima Medical University. 2016. Basic survey, appendix (estimated external radiation dose. Fukushima city 960–1295, Japan: Office of International Cooperation, Radiation Medical Science Center. http://fmu-global.jp/download/appendix-estimated-external-radiation-dose-16/.
   Google Scholar
• Fukushima Medical University. 2017. Thyroid ultrasound examination (first full-scale thyroid screening program). Fukushima city 960–1295, Japan: Office of International Cooperation, Radiation Medical Science Center. http://fmu-global.jp/download/thyroid-ultrasound-examination-first-full-scale-thyroid-screening-program-3/.
   Google Scholar
• Fukushima Medical University. 2018. Thyroid ultrasound examinations (second full-scale thyroid screening program). Fukushima city 960–1295, Japan: Office of International Cooperation, Radiation Medical Science Center. http://fmu-global.jp/download/thyroid-ultrasound-examinations-second-full-scale-thyroid-screening-program/.
   Google Scholar
• Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, Sugiyama H, Soda M, Ozasa K, Mabuchi K. 2013. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer. 132(5):1222–1226.
   PubMed Web of Science ®Google Scholar
• Grant EJ, Brenner A, Sugiyama H, Sakata R, Sadakane A, Utada M, Cahoon EK, Milder CM, Soda M, Cullings HM, et al. 2017. Solid cancer incidence among the life span study of atomic bomb survivors: 1958–2009. Radiat Res. 187(5):513–537.
   PubMed Web of Science ®Google Scholar
• Hall J, Jeggo PA, West C, Gomolka M, Quintens R, Badie C, Laurent O, Aerts A, Anastasov N, Azimzadeh O, et al. 2017. Ionizing radiation biomarkers in epidemiological studies – an update. Mutat Res. 771:59–84.
   PubMed Web of Science ®Google Scholar
• Hamatani K, Eguchi H, Ito R, Mukai M, Takahashi K, Taga M, Imai K, Cologne J, Soda M, Arihiro K, et al. 2008. RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose. Cancer Research. 68(17):7176–7182.
   PubMed Web of Science ®Google Scholar
• Handkiewicz-Junak D, Swierniak M, Rusinek D, Oczko-Wojciechowska M, Dom G, Maenhaut C, Unger K, Detours V, Bogdanova T, Thomas G, et al. 2016. Gene signature of the post-Chernobyl papillary thyroid cancer. Eur J Nucl Med Mol Imaging. 43(7):1267–1277.
   PubMed Web of Science ®Google Scholar
• Hatch M, Cardis E. 2017. Somatic health effects of Chernobyl: 30 years on. Eur J Epidemiol. 32(12):1047–1054.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Lagarde F, Tsuda N, Funamoto S, Preston DL, Koyama K, Mabuchi K, Ron E, Kodama K, Tokuoka S. 2010. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer. 116(7):1646–1655.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Morishita Y, Khattree R, Misumi M, Sasaki K, Hayashi I, Yoshida K, Kajimura J, Kyoizumi S, Imai K, et al. 2012. Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J. 26(11):4765–4773.
   PubMed Web of Science ®Google Scholar
• Heidenreich WF, Atkinson M, Paretzke HG. 2001. Radiation-induced cell inactivation can increase the cancer risk. Radiat Res. 155(6):870–872.
   PubMed Web of Science ®Google Scholar
• Heidenreich WF, Paretzke HG. 2008. Promotion of initiated cells by radiation-induced cell inactivation. Radiat Res. 170(5):613–617.
   PubMed Web of Science ®Google Scholar
• Kaiser JC, Jacob P, Meckbach R, Cullings HM. 2012. Breast cancer risk in atomic bomb survivors from multi-model inference with incidence data 1958–1998. Radiat Environ Biophys. 51(1):1–14.
   PubMed Web of Science ®Google Scholar
• Kaiser JC, Meckbach R, Eidemüller M, Selmansberger M, Unger K, Shpak V, Blettner M, Zitzelsberger H, Jacob P. 2016. Integration of a radiation biomarker into modeling of thyroid carcinogenesis and post-Chernobyl risk assessment. Carcinogenesis. 37(12):1152–1160.
   PubMed Web of Science ®Google Scholar
• Kocher DC, Apostoaei AI, Henshaw RW, Hoffman FO, Schubauer-Berigan MK, Stancescu DO, Thomas BA, Trabalka JR, Gilbert ES, Land CE. 2008. Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers. Health Phys. 95(1):119–147.
   PubMed Web of Science ®Google Scholar
• Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, Mabuchi K, Tronko MD, Nikiforov YE. 2013. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 119(10):1792–1799.
   PubMed Web of Science ®Google Scholar
• OECD. 2013. Guidance document on developing and assessing adverse outcome pathways. In Environment Directorate Joint Meeting of the Chemicals Committee and the Working Party on Chemicals. Paris: Organization for Economic Co-operation and Development (OECD).
   Google Scholar
• Ozasa K, Shimizu Y, Suyama A, Kasagi F, Soda M, Grant EJ, Sakata R, Sugiyama H, Kodama K. 2012. Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: an overview of cancer and noncancer diseases. Radiat Res. 177(3):229–243.
   PubMed Web of Science ®Google Scholar
• Pierce DA, Vaeth M, Cologne JB. 2008. Allowance for random dose estimation errors in atomic bomb survivor studies: a revision. Radiat Res. 170(1):118–126.
   PubMed Web of Science ®Google Scholar
• Preston RJ. 2015. Integrating basic radiobiological science and epidemiological studies: why and how. Health Phys. 108(2):125–130.
   PubMed Web of Science ®Google Scholar
• Preston RJ. 2017. Can radiation research impact the estimation of risk? Int J Radiat Biol. 93(10):1009–1014.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2018. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
   Google Scholar
• Rühm W, Eidemüller M, Kaiser JC. 2017. Biologically-based mechanistic models of radiation-related carcinogenesis applied to epidemiological data. Int J Radiat Biol. 93(10):1093–1117.
   PubMed Web of Science ®Google Scholar
• Selmansberger M, Braselmann H, Hess J, Bogdanova T, Abend M, Tronko M, Brenner A, Zitzelsberger H, Unger K. 2015. Genomic copy number analysis of Chernobyl papillary thyroid carcinoma in the Ukrainian-American cohort. Carcinogenesis. 36(11):1381–1387.
   PubMed Web of Science ®Google Scholar
• Selmansberger M, Feuchtinger A, Zurnadzhy L, Michna A, Kaiser JC, Abend M, Brenner A, Bogdanova T, Walch A, Unger K, et al. 2015. CLIP2 as radiation biomarker in papillary thyroid carcinoma. Oncogene. 34(30):3917–3925.
   PubMed Web of Science ®Google Scholar
• Selmansberger M, Kaiser JC, Hess J, Güthlin D, Likhtarev I, Shpak V, Tronko M, Brenner A, Abend M, Blettner M, et al. 2015. Dose-dependent expression of CLIP2 in post-Chernobyl papillary thyroid carcinomas. CARCIN. 36(7):748–756.
   PubMed Web of Science ®Google Scholar
• Takano T. 2017. Natural history of thyroid cancer [review]. Endocr J. 64(3):237–244.
   PubMed Web of Science ®Google Scholar
• Tronko M, Brenner AV, Bogdanova T, Shpak V, Oliynyk V, Cahoon EK, Drozdovitch V, Little MP, Tereshchenko V, Zamotayeva G, et al. 2017. Thyroid neoplasia risk is increased nearly 30 years after the Chernobyl accident. Int J Cancer. 141(8):1585–1588.
   PubMed Web of Science ®Google Scholar
• Tsuda T, Tokinobu A, Yamamoto E, Suzuki E. 2016. Thyroid cancer detection by ultrasound among residents ages 18 years and younger in Fukushima, Japan: 2011 to 2014. Epidemiology. 27(3):316–322.
   PubMed Web of Science ®Google Scholar
• Turner H, Firth D. 2015. Generalized nonlinear models in R: an overview of the gnm package. R package version 1.0-8. http://CRAN.R-project.org/package=gnm.
   Google Scholar
• Ulanowski A, Eidemüller M, Güthlin D, Kaiser JC, Shemiakina E, Jacob P. 2016. Quantitative Abschätzung des Strahlenrisikos unter Beachtung individueller Expositionsszenarien, Teil 2 – ProZES: a tool for assessment of assigned share of radiation in probability of cancer development (Part II). Neuherberg, Germany: Bundesamt Für Strahlenschutz (BfS). Report. No.: 0221–2016112214169.
   Google Scholar
• Venables WN, Ripley BD. 2002. Modern applied statistics with S. 4th ed. New York: Springer.
   Google Scholar
• Vinken M, Knapen D, Vergauwen L, Hengstler JG, Angrish M, Whelan M. 2017. Adverse outcome pathways: a concise introduction for toxicologists. Arch Toxicol. 91(11):3697–3707.
   PubMed Web of Science ®Google Scholar
• Xing M. 2013. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 13(3):184–199.
   PubMed Web of Science ®Google Scholar
• Yamashita S, Suzuki S, Suzuki S, Shimura H, Saenko V. 2018. Lessons from Fukushima: latest findings of thyroid cancer after the Fukushima nuclear power plant accident. Thyroid. 28(1):11–22.
   PubMed Web of Science ®Google Scholar
• Zablotska LB, Nadyrov EA, Rozhko AV, Gong Z, Polyanskaya ON, McConnell RJ, O'Kane P, Brenner AV, Little MP, Ostroumova E, et al. 2015. Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from Belarus exposed to radioiodines after the Chernobyl accident. Cancer. 121(3):457–466.
   PubMed Web of Science ®Google Scholar
• Zablotska LB, Ron E, Rozhko AV, Hatch M, Polyanskaya ON, Brenner AV, Lubin J, Romanov GN, McConnell RJ, O'Kane P, et al. 2011. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer. 104(1):181–187.
   PubMed Web of Science ®Google Scholar